Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Cell Therapy Raw Materials Market Expansion Outlook: What Revenue Opportunities Are Ahead?
The market size for cell therapy raw materials has shown substantial growth in recent years. It is anticipated to increase from $5.07 billion in 2025 to $6.1 billion in 2026, achieving a compound annual growth rate (CAGR) of 20.4%. The expansion observed during the historic period can be attributed to the early-stage progression of cell therapies, the dependence on animal-derived sera, the restricted scalability of cell culture procedures, the increasing volume of academic and clinical research in cell therapy, and rising investment in regenerative medicine.
The cell therapy raw materials market is set to experience substantial growth in the upcoming years. It is projected to reach $12.75 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 20.2%. This expansion during the projection period can be attributed to several factors, including the commercialization of cell and gene therapies, a surging demand for CAR-T treatments, progress in materials for cell expansion and cryopreservation, heightened regulatory oversight concerning raw material quality, and the increasing capacity for biopharmaceutical manufacturing. Furthermore, significant trends anticipated during the forecast encompass a greater emphasis on high-quality and consistent cell culture media, wider adoption of serum-free and chemically defined raw materials, expansion in the manufacturing pipelines for CAR-T and gene therapies, increased outsourcing to expert raw material providers, and a stronger focus on regulatory adherence and traceability.
Get A Free Sample Report With In-Depth Market Insights:
Cell Therapy Raw Materials Market Growth Backed By Core Demand Fundamentals
The expansion of the cell therapy raw materials market in the coming years is projected to be fueled by the increasing adoption of regenerative medicine. This medical domain concentrates on re-establishing or restoring normal bodily function through the replacement, engineering, or regeneration of human cells, tissues, or organs. The surge in regenerative medicine usage is attributed to the escalating prevalence of chronic and degenerative diseases, which necessitate treatments focused on repairing or replacing compromised tissues rather than just symptom management. Cell therapy raw materials are instrumental in propelling regenerative medicine forward by supplying vital components, such as growth factors, cell culture media, enzymes, and scaffolds. These are essential for cultivating, expanding, and maintaining the therapeutic cells utilized to mend or regenerate damaged tissues and organs. For instance, in January 2025, the National Library of Medicine, a US-based biomedical library, announced that 32 new gene therapies, including genetically modified cell therapies, were approved in 2024. Thus, the increasing application of regenerative medicine is a significant driver for the growth of the cell therapy raw materials market.
Cell Therapy Raw Materials Market Segment Outlook: Which Categories Are Growing Fastest?
The cell therapy raw materials market covered in this report is segmented –
1) By Therapy Area: Stem Cell Based Raw Materials, Gene Therapy Raw Materials, CAR-T Cell Therapy Raw Materials
2) By Product Type: Media, Sera, Cell Culture Supplements, Antibodies, Reagents And Buffers, Other Product Types
3) By End User: Biopharmaceutical And Pharmaceutical Companies, Contract Research Organization And Contract Manufacturing Organization, Other End Users
Subsegments:
1) By Stem Cell Based Raw Materials: Growth Factors, Cytokines, Cell Culture Media
2) By Gene Therapy Raw Materials: Transfection Reagents, Nucleotides And Enzymes, Cell Culture Media For Gene Modification
3) By Car-T Cell Therapy Raw Materials: T Cell Activation Reagents, Cell Expansion Media, Cryopreservation Agents
Cell Therapy Raw Materials Market Growth Trends Reshaping The Competitive Landscape
Companies operating in the cell therapy raw materials market are concentrating on creating innovative solutions, including manufacturing that adheres to good manufacturing practices (GMP), to guarantee product safety, consistency, and compliance with regulations across the cell therapy production lifecycle. Good manufacturing practice (GMP)-compliant manufacturing describes a system that ensures products are consistently manufactured and monitored according to quality benchmarks set by regulatory bodies, aiming to minimize risks in pharmaceutical and biotechnological production. For example, in April 2025, Thermo Fisher Scientific Inc., a US-based American life science and clinical research company, launched a US advanced therapies collaboration center (ATxCC) to support the advancement and commercialization of cell and gene therapies. This center expedites cell therapy development by offering comprehensive cGMP manufacturing support, advanced technologies, and expert process optimization, thereby encouraging collaboration to overcome manufacturing challenges and speed up commercialization.
Cell Therapy Raw Materials Market Leading Companies And Competitive Benchmarking
Major companies operating in the cell therapy raw materials market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Lonza Group AG, Sartorius Stedim Biotech SA, Bio-Techne Corporation, Stemcell Technologies Inc., Miltenyi Biotec GmbH, ACROBiosystems Co Ltd., CellGenix GmbH, Promocell GmbH, RoosterBio Inc., Akron Biotech LLC.
View The Full Cell Therapy Raw Materials Market Report:
Cell Therapy Raw Materials Market Regional Outlook: Where Is Opportunity Concentrated?
North America was the largest region in the cell therapy raw materials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy raw materials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model